168 related articles for article (PubMed ID: 17824552)
1. Targeted therapies in lung cancer: a tribute to advancements in clinical research.
McGee L
ONS Connect; 2007; 22(8 Suppl):27-8. PubMed ID: 17824552
[No Abstract] [Full Text] [Related]
2. Targeted therapies in colorectal carcinoma: addressing toxicities associated with EGFR inhibitors.
Biedrzycki BA
ONS Connect; 2007; 22(8 Suppl):33-4. PubMed ID: 17824555
[No Abstract] [Full Text] [Related]
3. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
4. Targeted therapies: aiming for the bull's-eye.
Gaguski ME
ONS Connect; 2007 Jul; 22(7):8-12. PubMed ID: 17694778
[No Abstract] [Full Text] [Related]
5. Updates in non-small cell lung cancer.
Walker S
Clin J Oncol Nurs; 2008 Aug; 12(4):587-96. PubMed ID: 18676326
[TBL] [Abstract][Full Text] [Related]
6. Novel therapies for non-small-cell lung cancer: a 2008 update.
Bunn PA
Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S6. PubMed ID: 19362947
[No Abstract] [Full Text] [Related]
7. Targeted therapies in breast cancer: challenging questions from oncology nurses.
Becze E
ONS Connect; 2007; 22(8 Suppl):31-2. PubMed ID: 17824554
[No Abstract] [Full Text] [Related]
8. Targeted therapies: a nursing perspective.
Kay P
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
[TBL] [Abstract][Full Text] [Related]
9. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
10. Targeted cancer. These "smart weapons" hit cancer in novel ways.
Held-Warmkessel J
Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487
[TBL] [Abstract][Full Text] [Related]
11. Advances in cancer therapy: targeted agents.
Gaguski ME; Begyn P
Nurs Manage; 2008 May; 39(5):45-8. PubMed ID: 18460908
[No Abstract] [Full Text] [Related]
12. Targeted lung cancer therapies.
Farmer G
Nat Rev Drug Discov; 2004 Jul; 3(7):547-8. PubMed ID: 15272497
[No Abstract] [Full Text] [Related]
13. Targeted therapies and non-small-cell lung cancer: work in progress?
Gridelli C
Curr Opin Oncol; 2006 Mar; 18(2):132-4. PubMed ID: 16462181
[No Abstract] [Full Text] [Related]
14. Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice.
Arteaga CL; Baselga J
Clin Cancer Res; 2003 May; 9(5):1579-89. PubMed ID: 12738709
[No Abstract] [Full Text] [Related]
15. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
16. Advanced non-small-cell lung cancer: new data, therapy choices, and challenging decisions.
Sandler AB
Oncology (Williston Park); 2006 May; 20(6):626-8. PubMed ID: 16773846
[No Abstract] [Full Text] [Related]
17. Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs.
Burris HA
Oncogene; 2009 Aug; 28 Suppl 1():S4-13. PubMed ID: 19680296
[TBL] [Abstract][Full Text] [Related]
18. The evolving story of the epidermal growth factor receptor as a target for non-small-cell lung cancer.
Lynch TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):786-7. PubMed ID: 16166955
[No Abstract] [Full Text] [Related]
19. Non-small cell lung cancer: new hope for a chronic illness.
Tyson LB
Oncol Nurs Forum; 2007 Sep; 34(5):963-70. PubMed ID: 17878125
[No Abstract] [Full Text] [Related]
20. Targeted therapy in lung cancer: the good, the bad, and the ugly.
Gadgeel SM
Clin Lung Cancer; 2009 Jan; 10(1):10-2. PubMed ID: 19289366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
